Skip to main content
Top

ASH 2024 Screening for iron deficiency in women is cost-effective

MedNet.nl: Screening and treating women with iron deficiency, defined as a ferritin level below 25 µg/L, is a cost-effective approach. According to a US study, this is true for both treatment with oral iron supplements and intravenous iron supplementation.

Are you up to date on targeted therapies for relapsed/refractory AML? 

Join Prof. Amer Zeidan and his expert guests to hear about innovations in molecular testing, emerging therapies, and IDH-targeted treatments, and get practical advice for improving your patient care.

Supported by: independent educational grant from Rigel

Find out more